Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hooton

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Lower genitourinary tract sources of seminal HIVRobert W Coombs, David Lockhart, Susan O Ross, et al.
The New England Journal of Medicine|March 15, 1990
Sexually transmitted diseases in victims of rapeC Jenny, T M Hooton, A Bowers, et al.
International Journal of Antimicrobial Agents|April 11, 2001
Urinary tract infection in adults: research priorities and strategiesA R Ronald, L E Nicolle, E Stamm, et al.
Plos One|December 18, 2009
Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in womenThomas R Hawn, Delia Scholes, Hongwei Wang, et al.
Lancet (London, England)|February 11, 2024
Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trialsFlorian Wagenlehner, Caroline R Perry, Thomas M Hooton, et al.
Radiology|November 1, 1992
Common carotid artery bifurcation: evaluation with spiral CT. Work in progressR B Schwartz, K M Jones, D M Chernoff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2011
Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infectionAnn E Stapleton, Melissa Au-Yeung, Thomas M Hooton, et al.
Infection and Immunity|September 12, 2012
Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tractRachel R Spurbeck, Paul C Dinh, Seth T Walk, et al.
The Journal of Infectious Diseases|September 1, 1992
Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitisM M Reddy, M H Grieco, G F McKinley, et al.
Frontiers in Immunology|March 28, 2024
Case report: Long-term follow-up of patients who received a FimCH vaccine for prevention of recurrent urinary tract infections caused by antibiotic resistant Enterobacteriaceae: a case report seriesElise Perer, Helen Stacey, Terri Eichorn, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Lower genitourinary tract sources of seminal HIVRobert W Coombs, David Lockhart, Susan O Ross, et al.
The New England Journal of Medicine|March 15, 1990
Sexually transmitted diseases in victims of rapeC Jenny, T M Hooton, A Bowers, et al.
International Journal of Antimicrobial Agents|April 11, 2001
Urinary tract infection in adults: research priorities and strategiesA R Ronald, L E Nicolle, E Stamm, et al.
Plos One|December 18, 2009
Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in womenThomas R Hawn, Delia Scholes, Hongwei Wang, et al.
Lancet (London, England)|February 11, 2024
Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trialsFlorian Wagenlehner, Caroline R Perry, Thomas M Hooton, et al.
Radiology|November 1, 1992
Common carotid artery bifurcation: evaluation with spiral CT. Work in progressR B Schwartz, K M Jones, D M Chernoff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2011
Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infectionAnn E Stapleton, Melissa Au-Yeung, Thomas M Hooton, et al.
Infection and Immunity|September 12, 2012
Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tractRachel R Spurbeck, Paul C Dinh, Seth T Walk, et al.
The Journal of Infectious Diseases|September 1, 1992
Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitisM M Reddy, M H Grieco, G F McKinley, et al.
Frontiers in Immunology|March 28, 2024
Case report: Long-term follow-up of patients who received a FimCH vaccine for prevention of recurrent urinary tract infections caused by antibiotic resistant Enterobacteriaceae: a case report seriesElise Perer, Helen Stacey, Terri Eichorn, et al.
Pageof 17